Ysabel Duron officially launched The Latino Cancer Institute (TLCI) in 2019, her latest venture. The California based Institute connects Latino cancer serving agencies nationwide to share best practices and develop capacity; convenes events for stakeholders in the cancer landscape to provide opportunities to collaborate with cancer researchers focused on Latino cancer challenges; advocates at a national level to raise awareness of Latino cancer issues, promote policy, and attract major funding stakeholders. Duron is a recognized key opinion leader about Latino cancer and community engagement issues. A 43-year award-winning TV journalist, Duron retired in 2013 to dedicate full-time to addressing the Latino cancer burden. Duron serves on the Independent Review Board (IRB) for the All of Us Research Program for the National Institutes of Health, the former Obama Precision Medicine Initiative. She was recently appointed to the Board of the California Institute for Regenerative Medicine, (CIRM), a taxpayer funded initiative supporting stem cell research.
This panel will consider Precision Medicine interventions along the cancer continuum which will demonstrate more effective health approaches to these populations.The discussion of emerging concepts challenges the focus merely on Precision Medicine, which alone will only exacerbate disparities.